Metraipolis › archive › dc_00c3829bb5fe

Real-World Experience with Brolucizumab in Treatment-Naïve nAMD with Low Baseline Visual Acuity: Short-Term Outcomes from a Prospective Single-Institution Study — Europe PMC PMID:42195311

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195311
DOI
10.3390/life16050754
License (as archived)
solo-consultazione
Archived
2026-11-02T22:32:51.017Z
SHA-256 of the archived text
0fdc0569c31f9dcbe8b3fc86503bf1d70e0078197b44be1359c8933e63ae74e4
Stable URL of this page
https://metraipolis.com/documento/dc_00c3829bb5fe

How to cite

Real-World Experience with Brolucizumab in Treatment-Naïve nAMD with Low Baseline Visual Acuity: Short-Term Outcomes from a Prospective Single-Institution Study — Europe PMC PMID:42195311 — Europe PMC (en), https://europepmc.org/article/MED/42195311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_00c3829bb5fe (Metraipolis archive dc_00c3829bb5fe, sha256 0fdc0569c31f9dcbe8b3fc86503bf1d70e0078197b44be1359c8933e63ae74e4)
BibTeX
@misc{dc00c3829bb5fe,
  title = {Real-World Experience with Brolucizumab in Treatment-Naïve nAMD with Low Baseline Visual Acuity: Short-Term Outcomes from a Prospective Single-Institution Study — Europe PMC PMID:42195311},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195311},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_00c3829bb5fe; sha256 0fdc0569c31f9dcbe8b3fc86503bf1d70e0078197b44be1359c8933e63ae74e4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195311. Agents can read the archived copy with the MCP tool read_document.